Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

ClinicalTrials.gov ID: NCT05456529

Public ClinicalTrials.gov record NCT05456529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label, One-Year Safety Study of Ruxolitinib Cream in Adolescents (Ages ≥ 12 Years to < 18 Years) With Atopic Dermatitis

Study identification

NCT ID
NCT05456529
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
103 participants

Conditions and interventions

Interventions

  • Ruxolitinib Cream Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2022
Primary completion
May 16, 2024
Completion
May 16, 2024
Last update posted
Jun 24, 2025

2022 – 2024

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
Arkansas Research Trials North Little Rock Arkansas 72117
First Oc Dermatology Fountain Valley California 92708
Dermatology Research Associates Los Angeles California 90045
Peninsula Research Associates Pra Rolling Hills Estates California 90274
Advanced Rx Clinical Research Group, Inc Westminster California 92683-4567
Encore Medical Research, Llc Hollywood Hollywood Florida 33021
Solutions Through Advanced Research, Inc Jacksonville Florida 32256
Acevedo Clinical Research Miami Florida 33142-2946
Skin Research of South Florida, Llc Miami Florida 33173
Well Pharma Medical Research Corp. Miami Florida 33173
Forward Clinical Trials Tampa Florida 33613
Iact Health Columbus Georgia 31904
Sneeze Wheeze and Itch Associates Llc Normal Illinois 61761-6280
Northshore University Health System Skokie Illinois 60077
Meridian Clinical Research Baton Rouge Louisiana 70808
Skin Specialists Pc the Advanced Skin Research Center Omaha Nebraska 68144
Empire Dermatology East Syracuse New York 13057
Sadick Dermatology Sadick Research Group New York New York 10075
Ohio Pediatric Research Association Dayton Ohio 45414
Aventiv Research Inc-Dublin Dublin Ohio 43016
Apex Clinical Research Center Mayfield Heights Ohio 44124
Lynn Health Science Institute Oklahoma City Oklahoma 73112
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130
Arlington Research Center Arlington Texas 76011
Progressive Clinical Research San Antonio Texas 78213
Jordan Valley Medical Center West Jordan Utah 84088-8873

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05456529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05456529 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →